Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer-Reference-Cited by-同舟云学术

Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer

Published:2019-04-03 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Okła Karolina,Czerwonka Arkadiusz,Wawruszak Anna,Bobiński Marcin,Bilska Monika,Tarkowski Rafał,Bednarek Wiesława,Wertel Iwona,Kotarski Jan

Funder

Uniwersytet Medyczny w Lublinie

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference54 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin.,2018

2. Impact of recurrence of ovarian cancer on quality of life and outlook for the future;Colombo;Int J Gynecol Cancer.,2017

3. Latest research and clinical treatment of advanced-stage epithelial ovarian cancer;Coleman;Nat Rev Clin Oncol.,2013

4. The tumor microenvironment at a glance;Balkwill;J Cell Sci.,2012

5. Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer;Lavoué;J Transl Med.,2013

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloid-derived suppressor cells in cancer: Current knowledge and future perspectives;International Immunopharmacology;2024-12

2. Recent advances in understanding the immune microenvironment in ovarian cancer;Frontiers in Immunology;2024-06-05

3. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives;Journal of Hematology & Oncology;2024-05-08

4. Bioinformatics-based screening and analysis of the key genes involved in the influence of antiangiogenesis on myeloid-derived suppressor cells and their effects on the immune microenvironment;Medical Oncology;2024-03-25

5. Immunotherapy Innovations in the Fight against Osteosarcoma: Emerging Strategies and Promising Progress;Pharmaceutics;2024-02-08